Our previous study suggested that the inhibition of innate immunity due to increased IL-10 production in subjects with IL-10 ht2 [A-C-C-T] may be associated with decreased total serum IgE levels in AD patients [32]. This evidence concerns the gene IL10 and Alzheimer disease.